Content about Pharmacist Society

June 7, 2011

Dr. Reddy's Labs has received regulatory approval from the Food and Drug Administration for generic versions of treatments for Alzheimer's disease, depression and breast cancer.

HYDERABAD, India — Dr. Reddy's Labs has received regulatory approval from the Food and Drug Administration for generic versions of treatments for Alzheimer's disease, depression and breast cancer.

The drug maker said that the FDA approved donepezil hydrochloride tablets, a generic version of Pfizer and Eisai's Arciept, in the 5-mg and 10-mg strengths for the treatment of Alzheimer's disease. Both strengths will be available in 30-, 90- and 500-count bottles.

June 7, 2011

The Food and Drug Administration reported Tuesday that U.S. marshals seized probiotic products from UAS Labs that were being marketed as drugs.

SILVER SPRING, Md. — The Food and Drug Administration reported Tuesday that U.S. marshals seized probiotic products from UAS Labs that were being marketed as drugs.

June 7, 2011

Global Wellness on Tuesday initiated a voluntary nationwide recall of its Via Extreme ultimate sexual enhancer dietary supplement for men.

HOLLYWOOD, Fla. — Global Wellness on Tuesday initiated a voluntary nationwide recall of its Via Extreme ultimate sexual enhancer dietary supplement for men.

The product — a bottle containing six blue-colored capsules per package — was distributed throughout the United States, Puerto Rico and Canada to Internet and retail consumers, the company reported.

Global Wellness is recalling only lots 809013 and 806030; the recall does not affect sales and distribution of Slim Extreme Gold and Gelslim, the company stated.

June 7, 2011

The Healthcare Distribution Management Association on Monday awarded eight leading pharmaceutical and consumer product manufacturers through the presentation of its annual Distribution Industry Awards for Notable Achievements in health care.

PHOENIX — The Healthcare Distribution Management Association on Monday awarded eight leading pharmaceutical and consumer product manufacturers through the presentation of its annual Distribution Industry Awards for Notable Achievements in health care.

June 7, 2011

Generic drug maker Lannett said that the Food and Drug Administration has assigned a Prescription Drug User Fee Act action date for one of Lannett's drugs.

PHILADELPHIA — Generic drug maker Lannett said that the Food and Drug Administration has assigned a Prescription Drug User Fee Act action date for one of Lannett's drugs.

The FDA said it revised its PDUFA goal date of June 23 for Lannett's new drug application for morphine sulfate oral solution.

"With a revised PDUFA date in 17 days, we are preparing for the relaunch of our morphine sulfate oral solution product, if approved,” Lannett president and CEO Arthur Bedrosian said.

June 7, 2011

A new report by Mintel may shed new light on the reasons why African-Americans diet.

CHICAGO — A new report by Mintel may shed new light on the reasons why African-Americans diet.

According to the research, while 70% of African-American adults surveyed said they limit the amount and/or kind of food they eat to boost their general wellness, 52% are eating healthier to prevent or control high blood pressure and 46% said they follow a diet to maintain their current weight.

June 7, 2011

Another generic drug maker has been given the green light to market its version of an Alzheimer's disease treatment.

PITTSBURGH — Another generic drug maker has been given the green light to market its version of an Alzheimer's disease treatment.

Mylan said that its subsidiary, Matrix Labs, has received final approval from the Food and Drug Administration to manufacture and market donepezil hydrochloride tablets in 5-mg and 10-mg strengths. The drug, a generic version of Pfizer and Eisai's Aricept, is used to treat dementia associated with Alzheimer's disease. Mylan said it will launch the product immediately.

June 7, 2011

Take Care Health Systems and Memorial Health on Tuesday announced a new relationship that will increase opportunities for clinical collaboration and improve patient access to high-quality, convenient and affordable healthcare options in the greater Jacksonville region.

JACKSONVILLE, Fla. — Take Care Health Systems and Memorial Health on Tuesday announced a new relationship that will increase opportunities for clinical collaboration and improve patient access to high-quality, convenient and affordable healthcare options in the greater Jacksonville region.

June 7, 2011

The Food and Drug Administration has accepted a regulatory approval application for a head lice treatment made by Topaz Pharmaceuticals, Topaz said Tuesday.

HORSHAM, Pa. — The Food and Drug Administration has accepted a regulatory approval application for a head lice treatment made by Topaz Pharmaceuticals, Topaz said Tuesday.

Topaz is seeking approval for ivermectin topical cream, for treating head lice in children and adults.

June 7, 2011

U.S. News Media Group on Tuesday ranked the best dieting plans by health goal — identifying the best plans for weight loss, heart health and diabetes.

WASHINGTON — U.S. News Media Group on Tuesday ranked the best dieting plans by health goal — identifying the best plans for weight loss, heart health and diabetes.

Building on the company’s experience evaluating hospitals, U.S. News developed five diet rankings to address a broad range of consumers' dieting goals and needs. Diets were ranked based on ratings from an independent panel of 22 experts.

June 7, 2011

The Food and Drug Administration has approved a generic contraceptive made by Watson Pharmaceuticals, the company said Tuesday.

PARSIPPANY, N.J. — The Food and Drug Administration has approved a generic contraceptive made by Watson Pharmaceuticals, the company said Tuesday.

Watson announced the approval of levonorgestrel and ethinyl estradiol tablets in the 0.09-mg/0.02-mg strength.

The drug is a generic version of Pfizer’s Lybrel, which had sales of slightly less than $12 million during the 12-month period that ended in April, according to IMS Health.

June 6, 2011

The Food and Drug Administration has approved a dozen new generic versions of a drug used to treat breast cancer, the agency said Monday.

SILVER SPRING, Md. — The Food and Drug Administration has approved a dozen new generic versions of a drug used to treat breast cancer, the agency said Monday.

The FDA said that on Friday it approved versions of Novartis’ drug Femara (letrozole) made by Teva Pharmaceuticals USA, Dr. Reddy’s Labs, Sun Pharmaceutical Industries, Impax Labs, Endo Pharmaceuticals, Roxane Labs, Accord Healthcare, Synthon Pharmaceuticals, Natco Pharma, Indicus Pharma, Fresenius Kabi Oncology and Kudco Ireland.

June 6, 2011

Cancer patients taking a drug made by Eli Lilly extended the amount of time they survived without their disease worsening, according to results of a study announced Sunday.

INDIANAPOLIS — Cancer patients taking a drug made by Eli Lilly extended the amount of time they survived without their disease worsening, according to results of a study announced Sunday.

Lilly said results of the phase-3 “PARAMOUNT” study of the injected drug Alimta (pemetrexed) extended progression-free survival in patients with nonsquamous nonsmall-cell lung cancer. The study focused on continuation maintenance when one of the same drugs used as a first-line treatment for cancer is continued as maintenance therapy in an effort to control the disease.

June 6, 2011

Registered dietitians' role in retail was emphasized as health-and-wellness professionals from retailers, manufacturers and other organizations gathered for the third annual Dietitian Summit, which was held in Philadelphia last month.

CHICAGO — Registered dietitians' role in retail was emphasized as health-and-wellness professionals from retailers, manufacturers and other organizations gathered for the third annual Dietitian Summit, which was held in Philadelphia last month.

The third annual invitation-only summit — co-hosted by Ahold USA and Field Trip Factory, which unites commerce and other organizations through education — underscored that grocers stress healthy food choices by utilizing RDs, which offer customers the tools to achieve optimal health.

June 6, 2011

AmeriCares and the Healthcare Distribution Management Association on Monday awarded the annual Power of Partnership Award to AstraZeneca for the company’s commitment to increasing access to health care for people in need, both here at home and throughout the developing world, during HDMA’s Business Leadership Conference on Monday.

PHOENIX — AmeriCares and the Healthcare Distribution Management Association on Monday awarded the annual Power of Partnership Award to AstraZeneca for the company’s commitment to increasing access to health care for people in need, both here at home and throughout the developing world, during HDMA’s Business Leadership Conference on Monday.

June 6, 2011

The Food and Drug Administration has found manufacturing issues at a plant owned by generic drug maker Impax Labs, the drug maker said Monday.

HAYWARD, Calif. — The Food and Drug Administration has found manufacturing issues at a plant owned by generic drug maker Impax Labs, the drug maker said Monday.

June 6, 2011

The Food and Drug Administration on Friday addressed the current outbreak of E. coli O104 in Europe.

SILVER SPRING, Md. — The Food and Drug Administration on Friday addressed the current outbreak of E. coli O104 in Europe.

The U.S. regulatory agency said that it has been in "routine contact" with the Centers of Disease Control and Prevention and the European Union to monitor the current outbreak of E. coli O104 and to track any illnesses in the United States that may be related to the outbreak.

June 6, 2011

A new survey sponsored by drug maker Novo Nordisk, which polled Type 1 and Type 2 diabetes patients in the United States, United Kingdom, Germany and France, found that about 1-in-5 respondents regularly are unable to attend a full day of work due to disruption caused by episodes of dangerously low blood sugar, also known as hypoglycemic events.

COPENHAGEN, Denmark — A new survey sponsored by drug maker Novo Nordisk, which polled Type 1 and Type 2 diabetes patients in the United States, United Kingdom, Germany and France, found that about 1-in-5 respondents regularly are unable to attend a full day of work due to disruption caused by episodes of dangerously low blood sugar, also known as hypoglycemic events.

June 6, 2011

Kerr Drug is hosting the North Carolina launch of the National Consumer League’s “Script Your Future” medication adherence campaign, the regional retail pharmacy chain said.

RALEIGH, N.C. — Kerr Drug is hosting the North Carolina launch of the National Consumer League’s “Script Your Future” medication adherence campaign, the regional retail pharmacy chain said.

June 6, 2011

Rite Aid is partnering with the Skin Cancer Foundation to launch a healthy skin care campaign for the summer, the retail pharmacy chain announced Monday.

CAMP HILL, Pa. — Rite Aid is partnering with the Skin Cancer Foundation to launch a healthy skin care campaign for the summer, the retail pharmacy chain announced Monday.

The campaign, which will last through July 26, will include free informational guides in all the chain’s stores and online, as well as promotions for skin care products and a national tour featuring free full-body skin cancer screenings by local dermatologists and advice from Rite Aid pharmacists.

June 6, 2011

The vaccines division of drug maker Sanofi donated vaccine doses on behalf of the Jeff Gordon Children's Foundation to Direct Relief International, which will aid victims of the recent storms in the Southeast and Midwest.

SWIFTWATER, Pa. — The vaccines division of drug maker Sanofi donated vaccine doses on behalf of the Jeff Gordon Children's Foundation to Direct Relief International, which will aid victims of the recent storms in the Southeast and Midwest.

June 6, 2011

An investigational drug improved diabetes and lipid control in patients with partial lipodystrophy, according to a new study.

SAN DIEGO — An investigational drug improved diabetes and lipid control in patients with partial lipodystrophy, according to a new study.

Amylin Pharmaceuticals announced Saturday results of a study of metreleptin, an analog of the human hormone leptin. Results of the study were presented at the 93rd annual meeting and expo of the Endocrine Society in Boston.

June 6, 2011

The White House on Friday held a roundtable discussion with approximately two dozen leaders across the public safety, healthcare and technology sectors to address how health information technology can help limit prescription drug abuse, the National Community Pharmacists Association noted in a release on Monday.

ALEXANDRIA, Va. — The White House on Friday held a roundtable discussion with approximately two dozen leaders across the public safety, healthcare and technology sectors to address how health information technology can help limit prescription drug abuse, the National Community Pharmacists Association noted in a release on Monday.

The main focus was how data from prescription drug monitoring programs can better facilitate prescribing, be incorporated into pharmacies and be leveraged in emergency rooms, the association stated.

June 3, 2011

Swedish drug maker Diamyd Medical has regained control of its investigational drug for Type 1 diabetes following Johnson & Johnson’s termination of a development deal between the two companies.

STOCKHOLM — Swedish drug maker Diamyd Medical has regained control of its investigational drug for Type 1 diabetes following Johnson & Johnson’s termination of a development deal between the two companies.

June 3, 2011

The gold standard long-term glucose monitoring test for patients with diabetes proved to be of limited value in dialysis patients, according to a new study at Wake Forest Baptist Medical Center released Wednesday.

WINSTON-SALEM, N.C. — The gold standard long-term glucose monitoring test for patients with diabetes proved to be of limited value in dialysis patients, according to a new study at Wake Forest Baptist Medical Center released Wednesday.